Empowering the immune System against cancer
Safe and effective drugs against cancerLindis Biotech
The Trifunctional, Bispecific Onco-Immune Company
Lindis Biotech is a clinical stage bio-pharmaceutical company that is committed to the development of Triomab® antibodies – a new class of T-cell engaging bispecific antibodies, empowering the immune system to turn malignant cancers into manageable and possibly curable diseases.
Profile
We combine scientific & pharmaceutical experience. We engage for safe and efficacious biomedical products.
Science
Triomab® antibodies induce a highly potent immune response against the tumor. Read more about Triomab® here.
Partnering
We welcome license or co-develop opportunities for our proprietary Triomab® antibody platform. We bring our partners comprehensive expertise in bio-pharmaceutical production as well as clinical development know-how in Triomab® antibodies.
Publications & News
In the context of our collaborations, we have significantly contributed to numerous articles published in peer-reviewed journals.
Contact
Find our contact informations here.
Image Credits: Pressmaster | 93974811 | Adobe Stock
Location
Lindis Biotech is located in the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried, Munich – one of the most vibrant biotech hot spots in Europe.